Holen Sie sich die Stockscreener-App
19.97
1.38%
-0.28
Schlusskurs vom Vortag:
$20.25
Offen:
$20.29
24-Stunden-Volumen:
1.01M
Relative Volume:
0.70
Marktkapitalisierung:
$2.44B
Einnahmen:
$460.48M
Nettoeinkommen (Verlust:
$142.80M
KGV:
16.92
EPS:
1.18
Netto-Cashflow:
$221.79M
1W Leistung:
-1.58%
1M Leistung:
-1.82%
6M Leistung:
-5.80%
1J Leistung:
-1.58%
1-Tages-Spanne:
$19.97
$20.52
1-Wochen-Bereich:
$19.60
$20.75
52-Wochen-Spanne:
$19.15
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
Firmenname
Catalyst Pharmaceuticals Inc
Sektor
Branche
Telefon
(305) 529-2522
Adresse
355 ALHAMBRA CIRCLE, CORAL GABLES
Vergleichen Sie CPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
19.97 | 2.42B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-11-18 | Eingeleitet | Stephens | Overweight |
| 2024-03-14 | Eingeleitet | Citigroup | Buy |
| 2024-03-07 | Eingeleitet | BofA Securities | Buy |
| 2023-12-21 | Eingeleitet | Oppenheimer | Outperform |
| 2022-08-24 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-07 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-10-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2016-04-26 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2014-09-30 | Bestätigt | ROTH Capital | Buy |
| 2014-09-16 | Bestätigt | ROTH Capital | Buy |
| 2014-09-15 | Bestätigt | H.C. Wainwright | Buy |
| 2013-10-21 | Bestätigt | Aegis Capital | Buy |
| 2013-09-24 | Eingeleitet | Maxim Group | Buy |
| 2013-09-06 | Bestätigt | Aegis Capital | Buy |
| 2013-04-18 | Eingeleitet | Aegis Capital | Buy |
| 2012-08-27 | Hochstufung | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| 2009-10-01 | Hochstufung | Merriman | Sell → Neutral |
| 2009-05-29 | Herabstufung | Hapoalim | Neutral → Underperform |
| 2009-05-29 | Herabstufung | Merriman Curhan Ford | Buy → Sell |
| 2008-12-15 | Eingeleitet | Merriman Curhan Ford | Buy |
| 2007-11-28 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-01-31 | Eingeleitet | Stifel Nicolaus | Buy |
| 2007-01-05 | Eingeleitet | First Albany | Buy |
Alle ansehen
Catalyst Pharmaceuticals Inc Aktie (CPRX) Neueste Nachrichten
AQR Capital Management LLC Decreases Position in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Rating of "Buy" by Analysts - MarketBeat
Insider Selling: Catalyst Pharmaceuticals (NASDAQ:CPRX) Insider Sells 30,000 Shares of Stock - MarketBeat
Jacobs Levy Equity Management Inc. Sells 406,554 Shares of Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Advisors Asset Management Inc. Has $4.34 Million Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
21,083 Shares in Catalyst Pharmaceuticals, Inc. $CPRX Purchased by Nomura Holdings Inc. - MarketBeat
Catalyst Pharmaceuticals, Inc. $CPRX Shares Purchased by Clark Capital Management Group Inc. - MarketBeat
New Vernon Capital Holdings II LLC Raises Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Is Catalyst Pharmaceuticals Inc.’s growth already priced inMarket Movement Recap & Long-Term Safe Investment Plans - Lancaster City Council
Is Catalyst Pharmaceuticals Inc. stock a falling knife or bargain buy2025 Macro Impact & Low Risk High Win Rate Stock Picks - Lancaster City Council
Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin - MSN
Is Catalyst Pharmaceuticals Inc. impacted by rising ratesIndex Update & Verified Momentum Stock Alerts - 뉴스영
State of Wyoming Reduces Stock Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Published on: 2025-09-07 06:18:36 - 뉴스영
What momentum shifts mean for Catalyst Pharmaceuticals Inc.2025 Analyst Calls & Consistent Profit Trading Strategies - Newser
Is Catalyst Pharmaceuticals Inc. gaining market shareBull Run & Free Technical Confirmation Trade Alerts - classian.co.kr
Trexquant Investment LP Increases Holdings in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Investors Don't See Light At End Of Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Tunnel - 富途牛牛
Catalyst Pharmaceuticals settles lawsuit with Lupin - MSN
What is the next catalyst for Zentalis Pharmaceuticals Inc.Trade Risk Summary & Verified Momentum Watchlists - خودرو بانک
Can Catalyst Pharmaceuticals Inc. maintain sales growthEarnings Recap Summary & AI Enhanced Trading Signals - خودرو بانک
Is Now a Good Time to Reenter Catalyst Pharmaceuticals Inc.2025 Support & Resistance & Technical Buy Zone Confirmations - beatles.ru
Published on: 2025-09-05 17:12:37 - beatles.ru
Catalyst Pharmaceuticals, Inc. $CPRX Shares Bought by Raymond James Financial Inc. - MarketBeat
Using R and stats models for Catalyst Pharmaceuticals Inc. forecastingQuarterly Portfolio Review & Low Risk High Win Rate Picks - Newser
How high can Catalyst Pharmaceuticals Inc. stock go2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
Catalyst Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Decliners & Community Trade Idea Sharing Platform - Newser
How to recover losses in Catalyst Pharmaceuticals Inc. stockJuly 2025 Sentiment & Expert Curated Trade Ideas - Newser
Catalyst Pharmaceuticals Inc. stock prediction for this weekJuly 2025 Institutional & Real-Time Chart Pattern Alerts - Newser
Smart tools for monitoring Catalyst Pharmaceuticals Inc.’s price actionPortfolio Performance Summary & AI Forecasted Entry/Exit Points - Newser
What is the next catalyst for Mirum Pharmaceuticals Inc.Trade Risk Report & Safe Capital Growth Stock Tips - khodrobank.com
Can Catalyst Pharmaceuticals Inc. outperform in the next rallyMarket Rally & Free Safe Entry Trade Signal Reports - خودرو بانک
Catalyst Pharmaceuticals Inc.’s volatility index tracking explainedJuly 2025 News Drivers & Expert-Curated Trade Recommendations - Newser
Is Catalyst Pharmaceuticals Inc. reversing from oversold territoryBull Run & Real-Time Chart Breakout Alerts - Newser
News impact scoring models applied to Catalyst Pharmaceuticals Inc.July 2025 PostEarnings & Safe Capital Investment Plans - Newser
Tools to assess Catalyst Pharmaceuticals Inc.’s risk profileTrade Volume Report & Daily Entry Point Alerts - Newser
Detecting support and resistance levels for Catalyst Pharmaceuticals Inc.July 2025 Earnings & Verified High Yield Trade Plans - Newser
Published on: 2025-09-03 23:26:43 - Newser
Statistical indicators supporting Catalyst Pharmaceuticals Inc.’s strengthPortfolio Growth Summary & High Conviction Buy Zone Picks - Newser
How to monitor Catalyst Pharmaceuticals Inc. with trend dashboardsMarket Performance Recap & Daily Technical Stock Forecast Reports - Newser
Risk adjusted return profile for Catalyst Pharmaceuticals Inc. analyzedJuly 2025 Short Interest & Breakout Confirmation Trade Signals - Newser
Catalyst Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
What is Catalyst Pharmaceuticals Inc. s 5 year growth outlookJuly 2025 Short Interest & Stepwise Swing Trade Plans - beatles.ru
What indicators show strength in Catalyst Pharmaceuticals Inc.July 2025 Drop Watch & Weekly Setup with High ROI Potential - Newser
How to read the order book for Catalyst Pharmaceuticals Inc.Trend Reversal & Safe Entry Momentum Tips - Newser
Should you hold or exit Catalyst Pharmaceuticals Inc. nowSwing Trade & Real-Time Volume Trigger Notifications - Newser
Is it time to cut losses on Catalyst Pharmaceuticals Inc.2025 Market WrapUp & Safe Capital Allocation Plans - Newser
Market reaction to Catalyst Pharmaceuticals Inc.’s recent newsWeekly Profit Report & Daily Chart Pattern Signals - Newser
How is Catalyst Pharmaceuticals Inc. managing supply chain issuesJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک
Is Catalyst Pharmaceuticals Inc. in a bullish channelJuly 2025 Technicals & AI Powered Market Entry Ideas - خودرو بانک
Finanzdaten der Catalyst Pharmaceuticals Inc-Aktie (CPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):